Increased expression of TGM2 has been observed in many types of cancer, including pancreatic cancer [30], breast cancer [31], malignant melanoma [32], ovarian cancer [33], lung cancer [34], and glioblastoma [35]. This evidence concerns the gene TGM2 and breast carcinoma.